Health ❯ Healthcare ❯ Medical Research ❯ Clinical Trials

Cancer Vaccines

BioNTech Terminates Phase 2 Colorectal Trial of Autogene Cevumeran as Shares Drop

An independent safety board found futility and an imbalance in overall survival, highlighting limits of single-agent mRNA vaccines compared with checkpoint-combination approaches.

26 ARTICLES

last mo.

Moderna and Merck Report Positive Phase 3 Result for Personalized mRNA Melanoma Vaccine

9 ARTICLES

8mo ago

Moderna–Merck Personalized Melanoma Vaccine Sustains 5-Year Benefit, Cutting Recurrence Risk by 49%

3 ARTICLES

9mo ago

Experimental Vaccine NOUS-209 Shows Early Promise in Preventing Colon Cancer in Lynch Syndrome

9 ARTICLES

last yr.

NHS Begins Phase II/III Trial of mRNA Vaccine for Head and Neck Cancer

8 ARTICLES

2y ago

First UK Patient Receives Promising Lung Cancer Vaccine